SCHEMBL1993074

SCHEMBL1993074

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(-c2cccc(C#N)c2)n[nH]1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.69
CNR1 P21554 4/20 0.39
CNR2 P34972 2/20 0.39
CYP1A2 P05177 6/20 0.37
CYP3A4 P08684 6/20 0.37
CLK4 Q9HAZ1 6/20 0.37
CYP2C19 P33261 5/20 0.37
LMNA P02545 4/20 0.37
CYP2D6 P10635 4/20 0.37
HDAC1 Q13547 3/20 0.37
ALDH1A1 P00352 5/20 0.36
HSD17B10 Q99714 4/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
USP2 O75604 3/20 0.36
MAPK1 P28482 3/20 0.36
ALOX15 P16050 2/20 0.36
HIF1A Q16665 1/20 0.36
MMP12 P39900 1/20 0.35
MMP13 P45452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989820 0.91 GHSR (0.78) GHSRCNR1CNR2HDAC1MEN1
SCHEMBL1992706 0.88 GHSR (0.72) GHSRHDAC1HDAC3HDAC4HDAC7
SCHEMBL1992391 0.88 GHSR (0.72) GHSRHDAC1ALDH1A1HSD17B10MAPK1
SCHEMBL1989790 0.88 GHSR (0.72) GHSRHDAC1HDAC3HDAC4HDAC7
SCHEMBL1996335 0.88 GHSR (0.72) GHSRCYP3A4HDAC1ALDH1A1HSD17B10
SCHEMBL1990507 0.87 GHSR (0.69) GHSRCNR1CNR2HDAC1HDAC3
SCHEMBL1984635 0.87 GHSR (0.69) GHSRCNR1CNR2CYP2C19CYP2D6
SCHEMBL1991593 0.86 GHSR (0.70) GHSRCYP3A4HDAC1ALDH1A1HSD17B10
SCHEMBL1983537 0.86 GHSR (0.74) GHSRCNR2HDAC1ALDH1A1HSD17B10
SCHEMBL1709709 0.84 GHSR (0.66) GHSRCNR1CNR2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885CNR1 459/4885CNR2 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.